UNGA GRUPPLEDARE

Ahtiainen Laura, doc. Imaging cellular mechanisms of epithelial

morphogenesis in development and disease Helsingfors universitet 45 000 Aitta­aho Teemu Heikki Juhani,

doc. Neural circuitry to limit binge eating Helsingfors universitet 40 000 Alinikula Jukka, FD Targeting and mis-targeting of somatic

hypermutation in lymphoma Åbo universitet 40 000

Almeida­Souza Leonardo, prof. Targeting the endocytic cytoskeleton for

cancer treatment Helsingfors universitet 40 000

Aro Aapo, doc. Electrocardiographic predictors of sudden

cardiac death HuS, Helsingfors

universitetssjukhus 40 000 Cheng Fang, prof. A single-cell approach to study the

mesenchymal cell heterogeneity in fibrosis Åbo Akademi 40 000 Färkkilä Anniina, MD Immunological vulnerabilities and biomarkers

in ovarian cancer Helsingfors universitet 40 000

Gordin Daniel, doc. Risk factors for covert and overt

cerebrovascular disease in patients with type 1 diabetes: a longitudinal long-term brain MRI follow-up study

folkhälsan 45 000

Granberg Kirsi, doc. Epigenetic regulation in diffuse glioma Tammerfors

universitet 40 000

Hirvonen Jussi, doc. Clinical value of magnetic resonance imaging

in head and neck disease Åbo universitet 45 000

Hollmén Maija, FD Breaking tolerance – improving cancer

immunotherapy Åbo universitet 40 000

Jacquemet Guillaume, FD Metastatic filopodia in cancer

progression (METfIL) Åbo Akademi 42 000

Kanninen Katja, doc. Targeting defective transmitophagy for

therapeutic benefit in Alzheimer's disease östra finlands

universitet, Kuopio 40 000 Kauppila Joonas, doc. Esophageal and gastric cancer in finland

and The finnish National Esophago-Gastric cancer cohort (fINEGo)-study.

uleåborgs universitet 40 000

Kero Jukka, doc. Molecular mechanisms of thyroid disorders –

from human diseases to mouse models Åbo universitet 50 000 Ketola Kirsi, FD The mechanisms of treatment-induced

prostate cancer cellular plasticity and resistance

östra finlands

universitet, Kuopio 45 000

Kivelä Riikka, doc. Targeting endothelial-to-mesenchymal

transition to treat cardiovascular diseases Helsingfors universitet 45 000 Koskimäki Janne, MD MiRNomes and brain recovery with plasticity

after acute brain injuries Åbo universitet 40 000

Kurppa Kari, FD Preventing and targeting minimal residual

disease following targeted cancer therapy Åbo universitet 40 000 Latonen Leena, doc. RNA regulatory pathways in the formation of

castration resistance in prostate cancer östra finlands

universitet, Kuopio 45 000 Lehtonen Sarka, doc. The role of glial cells in Parkinson’s disease östra finlands

universitet, Kuopio 40 000

Li Jianwei, doc. A dynamic molecular network approach for stable and responsive anticancer nanocarriers

Åbo universitet 40 000

Li Wei, FD Immunomodulation: towards effective and

safe inflammatory bowel disease therapy Helsingfors universitet 40 000 Linko Veikko, doc. Hybrid protein-DNA nanostructures for

nanobiomedicine Aalto-universitetet 40 000

Louvanto Karolina, MD Epigenetic and childhood factors associated with the susceptibility of HPV infections and cancer development

Åbo

universitetssjukhus 45 000

Malinen Anssi, doc. Development of ribosome biogenesis inhibitors as potential broad-specificity cancer drugs

Åbo universitet 42 000

Martikainen Riikka, doc. 3D-Cardiac microtissues for studying

mitochondrial cardiomyopathy östra finlands

universitet, Kuopio 40 000 Mattila Jaakko, FD Stem cell hunger and satiety – decoding

intestinal stem cell intrinsic nutrient sensing mechanisms

Helsingfors universitet 40 000

Mattila Ville, doc. Nordic Innovative Trial to Evaluate osteoPorotic fractures (NITEP study):

treatment of common osteoporotic fractures - a multicenter scandinavian RCT

Tammerfors

universitet 50 000

McWilliams Thomas, prof. Investigating non-canonical mitophagy in

severe juvenile neurodegeneration Helsingfors universitet 45 000 Mononen Mika, doc. Computational tool for predicting and

monitoring personalized progression of knee osteoarthritis

östra finlands

universitet, Kuopio 40 000

Paakinaho Ville, FD Cooperative reprogramming of steroid receptor signalling by androgenes and glucocorticoids in prostate cancer cells

östra finlands

universitet, Kuopio 45 000

Pasonen­Seppänen Sanna, doc. Hyaluronan in the formation of

immunosuppressive tumor microenvironment östra finlands

universitet, Kuopio 45 000 Pellinen Teijo, FD Spatial image profiling of tumour-stroma

interactions in cancer Helsingfors universitet 40 000 Peuhu Emilia, FD BreastClear: cytoskeletal and

niche-mediated regulation of stemness in normal and transformed breast epithelium

Åbo universitet 40 000

Pirinen Matti, doc. Geographic bias in genetic risk scores of

complex diseases in finland Institutet för molekylärmedicin i finland (fIMM)

45 000

Pitkänen Esa, doc. Integrative deep learning in acute leukemia

classification Helsingfors universitet 40 000

Poukkula Minna, FD Regulation of epithelial morphogenesis by

actin filament disassembly Helsingfors universitet 40 000 Prunskaite­Hyyryläinen Renata,

FD Detailed charcterization of novel testis

expressed genes and screens of small inhibitory molecule for male contraception

uleåborgs universitet 40 000

Raij Tuukka, doc. utilization of richness of naturalistic brain functioning to aid pathogenetic understanding and outcome prediction in first-episode psychosis

Aalto-universitetet 40 000

Rantakari Pia Tuulikki, FD Endothelial diaphragms in fetal leukocyte

migration Åbo universitet 45 000

Rinne Petteri, FD Melanocortin system as a regulator of cardiac remodeling – new diagnostic and therapeutic opportunities in heart failure

Åbo universitet 40 000

Saarikangas Juha, doc. Differentiation of cellular metabolism by

enzyme phase transitions Helsingfors universitet 40 000 Sahu Biswajyoti, FD Transposable elements as lineage-specific

enhancers in cancer Helsingfors universitet 45 000

Sarin Peter, doc. Translation and neoplasia – the multifaceted role of post-transcriptional transfer RNA modification

Helsingfors universitet 42 000

Sharma Vivek, FD Energy generation and reactive-oxygen species production by mitochondria, and its impact on health and disease

Helsingfors universitet 40 000

Toivonen Laura, MD The nasal airway microbiome, metabolome, and risk of asthma in children: a multiomic study

Åbo universitet 40 000

Totah Nelson, FD How the brain detects and stops mistakes Helsingfors universitet 39 000 Tukiainen Taru, TkD from genes to function – towards healthcare

solutions targeted for each sex Institutet för molekylärmedicin i finland (fIMM)

45 000

Ungureanu Daniela, doc. Identification of regulatory mechanisms of Wnt-related pseudokinases: from signalling modulators to targeted agents

Tammerfors

universitet 40 000

Vaahtomeri Kari, doc. Lymphatic endothelial cell interactions in guidance of lymphatic capillary growth and dendritic cell transmigration

Helsingfors universitet 40 000

Voutilainen Merja, doc. Elucidating therapeutic effects and mode of action of future trophic factors in ALS and Parkinson’s disease

Helsingfors universitet 40 000

Vuoristo Sanna, FD Novel biomarkers to predict developmental

potential of human embryo Helsingfors universitet 40 000 Vähärautio Anna, FD Tracing back resistance: mechanisms primed

in cancer cells before treatment Helsingfors universitet 45 000

STORSTIPENDIER (5 ÅR)

Kähäri Veli­Matti, prof. och Heino Jyrki, prof.

1:a året av 5

Molecular portraits of human skin cancer – novel molecular markers and therapeutic targets

Åbo universitet 250 000

Knip Mikael, prof.

3:e året av 5 The biodiversity hypothesis in type 1 diabetes and other immune-mediated diseases:

potential mechanisms

Helsingfors universitet 250 000

Silvennoinen Olli, prof.

5:e året av 5 Signaling in hematological diseases and

cancer: targeting the "undruggable" Tammerfors

universitet 250 000

Wartiovaara Anu, prof.

4:e året av 5 Anabolic roles of mitochondria in neurological disease and implications for therapy

Helsingfors universitet 250 000